TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DMAC

DiaMedica Therapeutics Inc

Healthcare · Biotechnology

6.90$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

DiaMedica Therapeutics Inc (DMAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -29 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DMAC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.8 -1.4 -3.0 -3.9 -5.7 -9.1 -9.2 -12 -12 -19 -22 -29
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -0.9
0.3 0.1 0.3 0.4 0.6 1.2 1.8 1.6 1.5 1.7 2.1 3.8
0.6 0.3 0.1 0.4 0.7 1.2 1.8 1.8 1.6
0.4 -0.1 -0.9 0.0 -0.6 0.4 1.2 -0.5 0.6 0.1 1.5 0.7
0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0
0.0 0.0 0.0 0.0 -0.1 -3.9 -16 -21 12 -18 8.6 -2.2
0.0 0.0 0.0 0.0 0.0
1.4 1.5 4.6 3.5 21 0.1 29
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.7 1.4 4.6 3.5 21 0.1 29 30 0.0 37 12 44
-2.1 0.0 1.6 -0.4 15 -13 3.5 -2.7 0.0 -0.2 -1.5 13
-3.8 -1.4 -3.0 -3.9 -5.7 -9.1 -9.2 -12 -12 -19 -22 -29

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?